PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes

PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Lipid Nutrition presents New Research on Clarinol(TM) CLA at DDW 2006 research shows that Clarinol™ CLA reduces fat mass in particular locations on the body, without any additional exercise, as subjects in placebo-controlled randmoized trial lost 2 kg of fat (equal to 4.4 lbs.) around the waist area and in the legs. Lipid Nutrition presents New Research on Clarinol(TM) CLA at DDW 2006 research shows that Clarinol™ CLA reduces fat mass in particular locations on the body, without any additional exercise, as subjects in placebo-controlled randmoized trial lost 2 kg of fat (equal to 4.4 lbs.) around the waist area and in the legs. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Probiotics From Nutraceutix Shown in Clinical Research to Enhance Immune Function As presented by university researchers at the North American Research Conference on Complementary and Integrative Medicine in Edmonton, probiotic tablets manufactured by Nutraceutix, Inc. were shown to enhance phagocytosis by monocytes and neutrophils in a healthy adult human population. Probiotics From Nutraceutix Shown in Clinical Research to Enhance Immune Function As presented by university researchers at the North American Research Conference on Complementary and Integrative Medicine in Edmonton, probiotic tablets manufactured by Nutraceutix, Inc. were shown to enhance phagocytosis by monocytes and neutrophils in a healthy adult human population. Probiotics From Nutraceutix Shown in Clinical Research to Enhance Immune Function As presented by university researchers at the North American Research Conference on Complementary and Integrative Medicine in Edmonton, probiotic tablets manufactured by Nutraceutix, Inc. were shown to enhance phagocytosis by monocytes and neutrophils in a healthy adult human population. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. PacificHealth Laboratories Reports Recent Research Results Investigators from James Madison University presented their findings at the 53rd Annual Meeting of the American College of Sports Medicine indicating that Accelerade improves parameters of exercise performance and decreases muscle fatigue, improves exercise endurance by 19%, decreases muscle damage by 75% and improves muscle functioning measured 24 hours later by 16% and in NCAA Division I cross-country runners, Accelerade reduces muscle damage by 27% and decreases muscle soreness by 30% compared to a carbohydrate-only sports drink. PacificHealth Laboratories Reports Recent Research Results Investigators from James Madison University presented their findings at the 53rd Annual Meeting of the American College of Sports Medicine indicating that Accelerade improves parameters of exercise performance and decreases muscle fatigue, improves exercise endurance by 19%, decreases muscle damage by 75% and improves muscle functioning measured 24 hours later by 16% and in NCAA Division I cross-country runners, Accelerade reduces muscle damage by 27% and decreases muscle soreness by 30% compared to a carbohydrate-only sports drink. Chrysantis Comments on Latest Eye Health Studies presented at ARVO 10,250 people attended the Association for Research in Vision and Ophthalmology (ARVO) annual conference earlier this month, learning that zeaxanthin supplementation to diabetic rats inhibited the increase in retinal oxidative stress and nutritive stress that is associated with the pathogenesis of retinopathy in diabetics. Chrysantis Comments on Latest Eye Health Studies presented at ARVO 10,250 people attended the Association for Research in Vision and Ophthalmology (ARVO) annual conference earlier this month, learning that zeaxanthin supplementation to diabetic rats inhibited the increase in retinal oxidative stress and nutritive stress that is associated with the pathogenesis of retinopathy in diabetics. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MATAWAN, N.J., May 31, 2006 (BUSINESS WIRE) -- PacificHealth Laboratories (PHLI) , a leading nutrition technology company, announced today that it has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. Professor David Thompson, leader of the Group that is based at Hope Hospital, will direct the research grant. Professor Thompson is one of the leading experts in the world on the neurology of the gut and the impact of appetite regulatory peptides such as cholecystokinin (CCK) on food intake. Professor Thompson's current research focuses on how specific nutrients can stimulate CCK and other appetite regulatory peptides. Dr. Robert Portman, President & CEO of PacificHealth Laboratories said, "This collaboration with Professor Thompson and his group at Manchester will have important and positive implications on both our weight loss and Type II diabetes research efforts. We have been working informally with Professor Thompson for almost two years. Studies conducted by his lab on our appetite suppressant technology have enabled us to enhance its effectiveness and provide the first clinical evidence that this technology may have enormous application in the management of patients with Type II diabetes." Dr. Portman continued, "Using a sophisticated assay, Professor Thompson has shown that our appetite suppressant formulation, which will be introduced under the brand name SATIETRIM(R), has a significant impact on gastric emptying. By slowing gastric emptying, SATIETRIM may have enormous utility in Type II diabetics by reducing peak insulin and glucose levels normally seen following consumption of a meal." Professor Thompson said, "The potential of activating appetite regulatory peptides represents an exciting approach to both weight control and management of Type II diabetes, which represent two of the major worldwide health problems today. Although there are major ongoing efforts on development of drugs to potentiate appetite regulatory peptides, the selective use of specific nutrients may represent a more effective and better long-term solution." About PacificHealth Laboratories. Inc.: PacificHealth Laboratories, Inc. (PHLI.OB), a leading nutrition technology company, has been a pioneer in discovering, developing and commercializing patented, protein-based nutritional products that stimulate specific peptides involved in appetite regulation and that activate biochemical pathways involved in muscle performance and growth. PHLI's principle areas of focus include weight loss, management of Type II diabetes and sports performance. To learn more, visit www.pacifichealthlabs.com. About the University of Manchester: The University of Manchester ( www.manchester.ac.uk) is the largest higher education institution in the UK, with 24 academic schools and over 36,000 students. Its Faculty of Medical & Human Sciences ( www.mhs.manchester.ac.uk) is one of the largest faculties of clinical and health sciences in Europe, with a research income of around GBP 51 million (almost a third of the University's total research income). The School of Medicine ( www.medicine.manchester.ac.uk) is the largest of the Faculty's five Schools, with 1,300 staff and almost 2,000 undergraduates. The School encompasses five teaching hospitals, and is closely linked to a range of general hospitals and community practices across the North West of England. Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software